Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
collagenase clostridium histolyticum collagen alpha-1(i) chain biotech NA drugbank , DGIDB Cellulitis[MeSHID:D002481]
Skin Ulcer[MeSHID:D012883]
Congenital Abnormality[MeSHID:D000013]
Body tissue[MeSHID:D014024]
Diagnosis[MeSHID:D003933]
Dupuytren Contracture[MeSHID:D004387]
Burn injury[MeSHID:D002056]
Peyronie Disease[MeSHID:D010411]
Senile Plaques[MeSHID:D058225]
penis[MeSHID:D010413]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Sarcoidosis[MeSHID:D012507]		 NA approved,investigational binder
collagenase clostridium histolyticum collagen alpha-1(i) chain biotech NA drugbank , DGIDB Cellulitis[MeSHID:D002481]
Skin Ulcer[MeSHID:D012883]
Congenital Abnormality[MeSHID:D000013]
Body tissue[MeSHID:D014024]
Diagnosis[MeSHID:D003933]
Dupuytren Contracture[MeSHID:D004387]
Burn injury[MeSHID:D002056]
Peyronie Disease[MeSHID:D010411]
Senile Plaques[MeSHID:D058225]
penis[MeSHID:D010413]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Sarcoidosis[MeSHID:D012507]		 2.27 approved,investigational binder
collagenase clostridium histolyticum collagen alpha-1(ii) chain biotech NA drugbank , DGIDB Cellulitis[MeSHID:D002481]
Skin Ulcer[MeSHID:D012883]
Congenital Abnormality[MeSHID:D000013]
Body tissue[MeSHID:D014024]
Diagnosis[MeSHID:D003933]
Dupuytren Contracture[MeSHID:D004387]
Burn injury[MeSHID:D002056]
Peyronie Disease[MeSHID:D010411]
Senile Plaques[MeSHID:D058225]
penis[MeSHID:D010413]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Sarcoidosis[MeSHID:D012507]		 NA approved,investigational binder
collagenase clostridium histolyticum collagen alpha-1(ii) chain biotech NA drugbank , DGIDB Cellulitis[MeSHID:D002481]
Skin Ulcer[MeSHID:D012883]
Congenital Abnormality[MeSHID:D000013]
Body tissue[MeSHID:D014024]
Diagnosis[MeSHID:D003933]
Dupuytren Contracture[MeSHID:D004387]
Burn injury[MeSHID:D002056]
Peyronie Disease[MeSHID:D010411]
Senile Plaques[MeSHID:D058225]
penis[MeSHID:D010413]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Sarcoidosis[MeSHID:D012507]		 2.27 approved,investigational binder
collagenase clostridium histolyticum collagen alpha-1(iii) chain biotech NA drugbank , DGIDB Cellulitis[MeSHID:D002481]
Skin Ulcer[MeSHID:D012883]
Congenital Abnormality[MeSHID:D000013]
Body tissue[MeSHID:D014024]
Diagnosis[MeSHID:D003933]
Dupuytren Contracture[MeSHID:D004387]
Burn injury[MeSHID:D002056]
Peyronie Disease[MeSHID:D010411]
Senile Plaques[MeSHID:D058225]
penis[MeSHID:D010413]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Sarcoidosis[MeSHID:D012507]		 2.27 approved,investigational binder
collagenase clostridium histolyticum collagen alpha-1(iii) chain biotech NA drugbank , DGIDB Cellulitis[MeSHID:D002481]
Skin Ulcer[MeSHID:D012883]
Congenital Abnormality[MeSHID:D000013]
Body tissue[MeSHID:D014024]
Diagnosis[MeSHID:D003933]
Dupuytren Contracture[MeSHID:D004387]
Burn injury[MeSHID:D002056]
Peyronie Disease[MeSHID:D010411]
Senile Plaques[MeSHID:D058225]
penis[MeSHID:D010413]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Sarcoidosis[MeSHID:D012507]		 NA approved,investigational binder
click here to return to the previous page